SCIENTIFIC AND ADMINISTRATIVE COMMITTEES AND ASSOCIATION APPOINTMENTS

Administrative director:
Mrs. Elizabeth Hooper, (office@iatdmct.org)

---


Administrative Committees

Awards Committee (Fund-raising)
R.Morris (Ray.Morris@nwahs.sa.gov.au)

Awards Committee (Selection)
Prof. M. Oellerich (moeller@med.uni-goettingen.de)

By-Laws Revision Committee
Prof. S. Soldin, Washington DC, USA
(ssoldin@cnmc.org)

Nominating & Elections Committee
Prof. H. H. Maurer (hans.maurer@uniklinik-saarland.de)

Congress Site Selection Committee
Prof. H. H. Maurer (hans.maurer@uniklinik-saarland.de)


2007 Congress Planning Committee
Prof. Pierre Marquet (marquet@unilim.fr)


---


Scientific Committees

Chiral Pharmacology Committee
J.M. Perel (pereljm@msx.upmc.edu)

Clinical Pharmacokinetics Committee
D. Touw (d.touw@ahz.nl)

Drugs of Abuse Committee
O.Drummer (olaf@vifm.org)

Immunosuppressive Drugs Committee
P. Wallemacq (wallemacq@lbcm.ucl.ac.be)

Impact of TDM on Pharmacoeconomics Committee
A. Vinks (sander.vinks@chmcc.org)

Pharmacogenetics Committee
M. Linder (mwlind01@homer.louisville.edu)
James Donnelly (james.donnelly@med.nyu.edu)

Standards of Practice Committee
C. Hiemke (hiemke@mail.uni-mainz.de)
E. Spencer (Edgar.Spencer@gstt.nhs.uk)

Certified reference materials
E. Billaud (Eliane.BILLAUD@hop.egp.ap-hop-paris.fr)

AIDS drug committee
N.Y. Rakhmanina (nrakhmanina@cnmc.org)
A. DasGupta (amitava.dasgupta@uth.tmc.edu)


IFCC/IATDMCT Joint working Group: Laboratory Practice Guidelines on Monitoring Immunosuppressive Drugs
D. Holt (dwhasil@aol.com)

 

---


Appointments

• Editorial Liaison to Executive: : M. Oellerich (Europe) (moeller@med.uni-goettingen.de), G. Koren (North America) (gkoren@sickkids.ca)
  
• Newsletter Editor: Dr. Kim Napoli (kimberly.napoli.eaton@uth.tmc.edu)
• Web Editor: A. Verstraete (alain.verstraete@ugent.be)